KR850000212B1 - 디벤조옥사제핀 유도체의 제법 - Google Patents

디벤조옥사제핀 유도체의 제법 Download PDF

Info

Publication number
KR850000212B1
KR850000212B1 KR1019810001793A KR810001793A KR850000212B1 KR 850000212 B1 KR850000212 B1 KR 850000212B1 KR 1019810001793 A KR1019810001793 A KR 1019810001793A KR 810001793 A KR810001793 A KR 810001793A KR 850000212 B1 KR850000212 B1 KR 850000212B1
Authority
KR
South Korea
Prior art keywords
compound
general formula
hours
preparing
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019810001793A
Other languages
English (en)
Korean (ko)
Other versions
KR830006249A (ko
Inventor
가즈오 사사하라
마사미쓰 혼다
마스오 고즈미
야스시 무라가미
도모히로 네이찌
히로시 나까기무라
유끼후미 노다
히로시 마쓰시따
슌이찌 하따
Original Assignee
쥬우가이세이야꾸 가부시끼 가이샤
우에노 기미오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쥬우가이세이야꾸 가부시끼 가이샤, 우에노 기미오 filed Critical 쥬우가이세이야꾸 가부시끼 가이샤
Publication of KR830006249A publication Critical patent/KR830006249A/ko
Application granted granted Critical
Publication of KR850000212B1 publication Critical patent/KR850000212B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019810001793A 1980-05-28 1981-05-23 디벤조옥사제핀 유도체의 제법 Expired KR850000212B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55-70176 1980-05-28
JP7017680A JPS56166180A (en) 1980-05-28 1980-05-28 Dibenzoxazepine derivative and its preparation

Publications (2)

Publication Number Publication Date
KR830006249A KR830006249A (ko) 1983-09-20
KR850000212B1 true KR850000212B1 (ko) 1985-03-06

Family

ID=13423954

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810001793A Expired KR850000212B1 (ko) 1980-05-28 1981-05-23 디벤조옥사제핀 유도체의 제법

Country Status (11)

Country Link
US (1) US4435391A (https=)
EP (1) EP0040860B1 (https=)
JP (1) JPS56166180A (https=)
KR (1) KR850000212B1 (https=)
AT (1) ATE6645T1 (https=)
CA (1) CA1162189A (https=)
DE (1) DE3162614D1 (https=)
HU (1) HU183456B (https=)
IL (1) IL62894A (https=)
MX (1) MX157054A (https=)
ZA (1) ZA813385B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240721A3 (en) * 1986-03-12 1991-01-02 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for the treatment of peripheral circulatory disorders
PT805155E (pt) * 1994-09-28 2002-09-30 Nippon Suisan Kaisha Ltd Novo composto heterociclico condensado, anti-oxidante triciclico
WO1996033983A1 (en) * 1995-04-25 1996-10-31 Daiichi Radioisotope Laboratories, Ltd. Dibenzoxazepine n-oxide derivatives and drug containing the same as the active ingredient
JP4582366B2 (ja) * 1998-11-30 2010-11-17 東レ・ファインケミカル株式会社 ピロリジン誘導体の製造法
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
EP1954696B1 (en) * 2005-01-19 2011-02-23 Bristol-Myers Squibb Company 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
DE602006020871D1 (de) * 2005-06-27 2011-05-05 Bristol Myers Squibb Co Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden
AR056867A1 (es) * 2005-06-27 2007-10-31 Bristol Myers Squibb Co Antagonistas heterociclicos n- enlazados del receptor de p2y1 utiles en el tratamiento de condiciones tromboticas. composiciones farmaceuticas.
WO2007002634A1 (en) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
EP1899299B1 (en) * 2005-06-27 2010-10-20 Bristol-Myers Squibb Company C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
US20080090805A1 (en) * 2005-10-17 2008-04-17 Acadia Pharmaceuticals Inc. Cb-1 modulating compounds and their use
CA2625423A1 (en) * 2005-10-17 2007-04-26 Acadia Pharmaceuticals Inc. Cb-1 modulating compounds and their use
US7960569B2 (en) * 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
CN101889000B (zh) * 2007-12-05 2012-11-28 詹森药业有限公司 二苯并氮杂*和二苯并氧氮杂*trpa1激动剂
WO2019173761A1 (en) 2018-03-09 2019-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473141A (de) 1965-12-30 1969-05-31 Wander Ag Dr A Verfahren zur Herstellung 11-aminoalkylierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,f)-1,4-thiazepine
US3646009A (en) 1967-03-15 1972-02-29 Boehringer & Soehne Gmbh Anti-diabetically active sulfonyl-semicarbazides
US3458516A (en) 1968-02-16 1969-07-29 American Cyanamid Co 11-(piperazinyl)dibenz(b,f)(1,4)oxazepines and analogous thiazepines
DE2014223A1 (de) 1969-03-28 1970-10-01 Sumitomo Chemical Company Ltd., Osaka (Japan) Benzoxazepin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
JPS5576869A (en) * 1978-12-06 1980-06-10 Chugai Pharmaceut Co Ltd Dibenzoxazepine derivative and its preparation

Also Published As

Publication number Publication date
CA1162189A (en) 1984-02-14
US4435391A (en) 1984-03-06
MX157054A (es) 1988-10-24
HU183456B (en) 1984-05-28
EP0040860B1 (en) 1984-03-14
ZA813385B (en) 1982-06-30
DE3162614D1 (en) 1984-04-19
IL62894A (en) 1984-10-31
ATE6645T1 (de) 1984-03-15
JPS56166180A (en) 1981-12-21
JPH0223550B2 (https=) 1990-05-24
KR830006249A (ko) 1983-09-20
IL62894A0 (en) 1981-07-31
EP0040860A1 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
KR850000212B1 (ko) 디벤조옥사제핀 유도체의 제법
PT97507B (pt) Processo para apreparacao de novos derivados de catecol farmacologicamente activos
HU204802B (en) Process for producing new benzoxazine and benzthiazine derivatives and pharmaceutical compositions comprising such compounds
PT1142885E (pt) Derivados de 2-(n-cianoimino)tiazolidin-4-ona
NO823829L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
JPH0370698B2 (https=)
JPS60184077A (ja) 抗炎症性オキシム前駆薬
US3923996A (en) 3-Substituted-oxindoles in compositions and methods of treating obesity
US4552876A (en) Bisbenzoxazines and pharmaceutical use
JPH0680059B2 (ja) 新規なイソオキサゾール誘導体
JPH0370700B2 (https=)
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
US4288596A (en) Furoindoles
CA1125762A (en) Dihydronicotinic acid derivatives and process for the preparation thereof
US3763169A (en) Isonipecotic acid compounds
HU194213B (en) Process for production of 3-alkoxi-2-n-pirrolidin-n-piridil-n-furil /or n-tienil/-methil-prophil amins
US4405633A (en) Method of treatment of asthma
IL37588A (en) 2h-pyrimido (2,1-a) isoquinolin-2-ones,their preparation and pharmaceutical compositions containing them
US4820837A (en) 1-hydroxy-oxo-5H-pyrido(3,2-a)phenoxazine-3-carboxylic acid esters
JPS63233992A (ja) ジヒドロピリジン−５−ホスホン酸環状エステル類
US3845074A (en) Dibenzo(b,f)thiazepin(1,4)-11-yl amino alkanoic acids
EP0197533B1 (en) Dioxolobenzisoxazole derivatives and process for preparing the same
US4605660A (en) Indeno[2,1-c]pyridine compounds, and their use as calcium channel blockers
JPH1129471A (ja) クマリン誘導体を薬効成分として含有する肝疾患治療剤

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19930307

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19930307